Burek B, Hrsak I
Department of Experimental Biology and Medicine, Ruder Bosković Institute, Zagreb, Croatia.
Immunol Lett. 1995 Mar;45(3):185-8. doi: 10.1016/0165-2478(95)00002-m.
Spleen macrophages from 1- and 4-month-old preleukemic AKR mice were stimulated in vitro with the bacterial immunomodulators lipopolysaccharide (LPS), peptidoglycan monomer (PGM) and muramyl dipeptide (MDP), in order to study their migration ability and mitochondrial enzyme activity. Macrophages from 1-month-old AKR mice, characterized by higher functional activity, failed to demonstrate any changes in the parameters studied after in vitro stimulation with the employed compounds. Conversely, the depressed macrophage function, spontaneously developed in 4-month-old AKR mice, most probably related to the preleukemic state, improved significantly and to about the same extent with all three immunomodulators.
为了研究1月龄和4月龄白血病前期AKR小鼠脾脏巨噬细胞的迁移能力和线粒体酶活性,用细菌免疫调节剂脂多糖(LPS)、肽聚糖单体(PGM)和胞壁酰二肽(MDP)对其进行体外刺激。1月龄AKR小鼠的巨噬细胞功能活性较高,在用上述化合物进行体外刺激后,所研究的参数未显示任何变化。相反,4月龄AKR小鼠自发出现的巨噬细胞功能抑制,很可能与白血病前期状态有关,在使用所有三种免疫调节剂后均有显著改善,且改善程度大致相同。